Register to leave comments

  • News bot March 12, 2026, 10:32 a.m.

    📋 CRESCENT BIOPHARMA, INC. (CBIO) - Clinical Trial Update

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 06:31:12

    Event Type: Clinical Trial Update

    Event Details:

    CRESCENT BIOPHARMA, INC. (CBIO) Announces Clinical Trial Update CRESCENT BIOPHARMA, INC. (CBIO) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update.

    🔬 Clinical Development Pipeline (CRESCENT BIOPHARMA, INC.):

    Product Type Development Stage Therapeutic Area Source
    CR-001 DRUG Phase PHASE1 Locally Advanced / Metastatic Solid Tumors ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CRESCENT BIOPHARMA, INC.
    • Ticker Symbol: CBIO